Format

Send to

Choose Destination
Int J Cardiol. 2014 Aug 1;175(2):380-2. doi: 10.1016/j.ijcard.2014.05.042. Epub 2014 May 17.

Comparison of the longevity of implantable cardioverter-defibrillator devices by different manufacturers.

Author information

1
Department of Medicine, Mayo Clinic, Rochester, MN, USA.
2
Department of Cardiology, Athens Euroclinic, Athens, Greece; Medical and Radiation Physics, Department of Radiology, University of Athens, Greece.
3
Department of Cardiology, Athens Euroclinic, Athens, Greece. Electronic address: dkatritsis@euroclinic.gr.

KEYWORDS:

Cardiac resynchronization therapy; Device longevity; Implantable cardioverter-defibrillator

PMID:
24874912
DOI:
10.1016/j.ijcard.2014.05.042
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center